332 related articles for article (PubMed ID: 3157564)
1. Hyperprolactinemia decreases the luteinizing hormone-releasing hormone concentration in pituitary portal plasma: a possible role for beta-endorphin as a mediator.
Sarkar DK; Yen SS
Endocrinology; 1985 May; 116(5):2080-4. PubMed ID: 3157564
[TBL] [Abstract][Full Text] [Related]
2. D-Trp-6-luteinizing hormone-releasing hormone inhibits hyperprolactinemia in female rats.
Debeljuk L; Torres-Alemán I; Schally AV
Endocrinology; 1985 Jun; 116(6):2227-31. PubMed ID: 3158510
[TBL] [Abstract][Full Text] [Related]
3. Prolactin suppresses luteinizing hormone secretion and pituitary responsiveness to luteinizing hormone-releasing hormone by a direct action at the anterior pituitary.
Cheung CY
Endocrinology; 1983 Aug; 113(2):632-8. PubMed ID: 6347662
[TBL] [Abstract][Full Text] [Related]
4. Suppression of pulsatile LH secretion, pituitary GnRH receptor content and pituitary responsiveness to GnRH by hyperprolactinemia in the male rat.
Fox SR; Hoefer MT; Bartke A; Smith MS
Neuroendocrinology; 1987 Oct; 46(4):350-9. PubMed ID: 2823160
[TBL] [Abstract][Full Text] [Related]
5. [Possible mechanisms of the interaction between gonadotropins and prolactin in an experimental hyperprolactinemia model].
Tresguerres JA; Esquifino AI
Acta Physiol Lat Am; 1983; 33(3):257-74. PubMed ID: 6424409
[TBL] [Abstract][Full Text] [Related]
6. The effect of hyperprolactinemia produced by transplantable pituitary MtTW15 tumor cells in male rats on hypothalamic luteinizing hormone-releasing hormone release in vitro: effects of naloxone and K+.
Kalra PS; Kalra SP
Endocrinology; 1987 Jul; 121(1):310-5. PubMed ID: 3297642
[TBL] [Abstract][Full Text] [Related]
7. Opioid effects on plasma concentrations of luteinizing hormone and prolactin in the adult male rhesus monkey.
Gilbeau PM; Almirez RG; Holaday JW; Smith CG
J Clin Endocrinol Metab; 1985 Feb; 60(2):299-305. PubMed ID: 2981242
[TBL] [Abstract][Full Text] [Related]
8. The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion.
Baranowska B; Rozbicka G; Jeske W; Abdel-Fattah MH
J Clin Endocrinol Metab; 1984 Sep; 59(3):412-6. PubMed ID: 6086696
[TBL] [Abstract][Full Text] [Related]
9. Altered sensitivity to an opiate antagonist, naloxone, in hyperprolactinemic male rats.
Sweeney CA; Morgan WW; Smith MS; Bartke A
Neuroendocrinology; 1985 Jul; 41(1):1-6. PubMed ID: 3895021
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of luteinizing hormone during hyperprolactinemia: response to central administration of antagonists of corticotropin-releasing factor.
de Greef WJ; Ooms MP; Vreeburg JT; Weber RF
Neuroendocrinology; 1995 Jan; 61(1):19-26. PubMed ID: 7731494
[TBL] [Abstract][Full Text] [Related]
11. Changes in beta-endorphin-like immunoreactivity in pituitary portal blood during the estrous cycle and after ovariectomy in rats.
Sarkar DK; Yen SS
Endocrinology; 1985 May; 116(5):2075-9. PubMed ID: 3157563
[TBL] [Abstract][Full Text] [Related]
12. Estrogen inhibits luteinizing hormone (LH), but not follicle-stimulating hormone secretion in hypophysectomized pituitary-grafted rats receiving pulsatile LH-releasing hormone infusions.
Strobl FJ; Levine JE
Endocrinology; 1988 Jul; 123(1):622-30. PubMed ID: 3133202
[TBL] [Abstract][Full Text] [Related]
13. Corticotropin-releasing factor decreases plasma luteinizing hormone levels in female rats by inhibiting gonadotropin-releasing hormone release into hypophysial-portal circulation.
Petraglia F; Sutton S; Vale W; Plotsky P
Endocrinology; 1987 Mar; 120(3):1083-8. PubMed ID: 3542513
[TBL] [Abstract][Full Text] [Related]
14. Site of action for beta-endorphin-induced changes in plasma luteinizing hormone and prolactin in the ovariectomized rat.
Wiesner JB; Koenig JI; Krulich L; Moss RL
Life Sci; 1984 Apr; 34(15):1463-73. PubMed ID: 6323905
[TBL] [Abstract][Full Text] [Related]
15. Hyperprolactinemia inhibits gonadotropin-releasing hormone (GnRH) stimulation of the number of pituitary GnRH receptors.
Garcia A; Herbon L; Barkan A; Papavasiliou S; Marshall JC
Endocrinology; 1985 Sep; 117(3):954-9. PubMed ID: 2990879
[TBL] [Abstract][Full Text] [Related]
16. Diurnal variation in luteinizing hormone-releasing hormone and beta-endorphin release in pituitary portal plasma during the rat estrous cycle.
Sarkar DK; Minami S
Biol Reprod; 1995 Jul; 53(1):38-45. PubMed ID: 7669855
[TBL] [Abstract][Full Text] [Related]
17. Relationship between luteinizing hormone releasing hormone concentration in hypophysial portal blood and luteinizing hormone release in intact, castrated, and electrochemically-stimulated rats.
Eskay RL; Mical RS; Porter JC
Endocrinology; 1977 Feb; 100(2):263-70. PubMed ID: 318992
[TBL] [Abstract][Full Text] [Related]
18. Posterior pituitary involvement in the control of luteinizing hormone and prolactin secretion during the estrous cycle.
Froehlich JC; Ben-Jonathan N
Endocrinology; 1984 Apr; 114(4):1059-64. PubMed ID: 6423366
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide-Y enhances luteinizing hormone (LH)-releasing hormone-induced LH release and elevations in cytosolic Ca2+ in rat anterior pituitary cells: evidence for involvement of extracellular Ca2+ influx through voltage-sensitive channels.
Crowley WR; Shah GV; Carroll BL; Kennedy D; Dockter ME; Kalra SP
Endocrinology; 1990 Sep; 127(3):1487-94. PubMed ID: 1696888
[TBL] [Abstract][Full Text] [Related]
20. Does beta-endorphin modulate basal and dopamine-inhibited prolactin release by an action at the anterior pituitary?
Cheung CY
Neuroendocrinology; 1984 Dec; 39(6):489-95. PubMed ID: 6096753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
